Deep Track Capital, LP Olema Pharmaceuticals, Inc. Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 3,442,833 shares of OLMA stock, worth $14.2 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
3,442,833
Previous 3,442,833
-0.0%
Holding current value
$14.2 Million
Previous $20.1 Million
35.5%
% of portfolio
0.45%
Previous 0.88%
Shares
4 transactions
Others Institutions Holding OLMA
# of Institutions
135Shares Held
64.3MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$28.2 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$27.8 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$21.8 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$16.5 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.21MShares$13.2 Million2.35% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $167M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...